Posted August 18, 2006

Restitution Program for Purchases of Lane Labs' Products

On August 17, 2006 the Food and Drug Administration (FDA) announced that it was notifying consumers of a restitution (refund) program for purchasers of three of Lane Labs-USA, Inc.'s products. The products are BeneFin, MGN-3 and SkinAnswer. Consumers who purchased those products between September 22, 1999 and July 12, 2004 are eligible for a partial refund of the purchase price and any shipping and handling costs.

A federal District Court in Newark, New Jersey has ruled that Lane Labs marketed BeneFin, MGN-3 and SkinAnswer as treatments for cancer, HIV, and skin cancer without FDA approval. See .

The Court ordered Lane Labs to pay restitution to persons who purchased the products between September 22, 1999 and July 12, 2004. The Court also appointed Newark, New Jersey attorney Donald A. Robinson as Special Master to oversee the restitution process. Gilardi & Co., LLC has been retained to assist with the restitution process.

For more information, go to the web address below.